This is a working overview of RP-HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-11-11. Anything still debated is marked as such rather than presented as settled.
Solubility behavior is a practical concern for handling. Selank dissolves readily in water and in common aqueous buffers, which simplifies preparation of working solutions. The choice of solvent, ionic strength, and pH can influence aggregation over time, particularly at higher concentrations. Aqueous solutions are typically sterile-filtered before use. Because stability depends on several variables, storage and handling notes should be treated as general guidance rather than fixed rules, and specific values are best confirmed against a certificate of analysis for each batch.
Characterization of Selank in a laboratory setting relies on standard peptide methods. Reverse-phase high-performance liquid chromatography separates the target from related impurities and provides a purity figure, commonly reported as 95 percent or higher. Mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, confirms the molecular mass and helps detect truncation or modification. Amino acid analysis can verify composition when a sequence-level check is needed. These techniques together establish identity and purity for a given lot.
Outside its country of origin the compound is generally handled as a research chemical rather than an approved medicine. No regulatory approval from the United States Food and Drug Administration or the European Medicines Agency has been granted for human use. Identity and purity are normally checked by reverse-phase high-performance liquid chromatography, with mass spectrometry used to confirm the molecular mass. Lyophilised material is stored cold and desiccated, and repeated freeze-thaw cycles are avoided.
Published work on this peptide almost always uses intranasal delivery, with drops or a spray applied to the nasal mucosa. Some animal experiments have used subcutaneous or intraperitoneal injection, and a smaller number have compared routes directly. Oral administration is not a focus of the literature, because short peptides of this size are broken down by digestive enzymes and cross intestinal barriers poorly. How much of an intranasal dose reaches the bloodstream intact in humans remains an open question.
| Property | Value | Notes |
|---|---|---|
| Solubility | Freely soluble in water | Also in aqueous buffers |
| Typical purity (HPLC) | 95 percent or higher | Lot-dependent |
| Dry powder storage | Minus 20 degrees Celsius | Sealed, dry, protected from light |
| Solution storage | 2 to 8 degrees Celsius | Short-term use |
| Identity confirmation | Mass spectrometry | ESI or MALDI-TOF |
Handling follows standard practice for research peptides. Material is weighed in a low-humidity environment because the powder absorbs atmospheric moisture. Purity is reported as the percentage area of the main peak in a chromatogram, with specifications commonly set at 95 percent or higher; values below that threshold indicate the presence of truncated or modified species. Residual trifluoroacetate from purification is often present and may affect mass balance. Certificates of analysis should state the analytical method, the column and gradient used, and the lot-specific retention time so that results can be compared across suppliers.
Identity and purity of selank are established with reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The peptide elutes from C18 columns with acetonitrile gradients in water containing trifluoroacetic acid or formic acid, and detection is usually performed by ultraviolet absorbance near 214 nm. Electrospray ionization in positive mode gives a doubly protonated ion near m/z 377, consistent with a mass of about 752 Da. Amino acid analysis or tandem mass spectrometry of fragment ions confirms the sequence. Because the molecule has no aromatic residues, it lacks a usable 280 nm chromophore, so low-wavelength detection or mass spectrometry is required.
Peptide bonds in selank are susceptible to hydrolysis under strongly acidic or basic conditions, and the terminal proline residues are vulnerable to exopeptidase activity in biological samples. Lyophilized powder stored dry at -20 °C typically remains stable for extended periods, whereas aqueous solutions degrade faster and may lose measurable purity within days to weeks depending on pH, temperature, and microbial load. Repeated freeze-thaw cycles promote aggregation and adsorption to container surfaces. For analytical work, solutions are usually prepared fresh, kept cold, and used within a single working day.
Selank is not a naturally occurring peptide and has no known endogenous counterpart in human physiology. Russian-language sources frequently call it TP-7, while English-language sources use the name Selank almost exclusively. Database indexing is uneven, partly because early reports appeared in regional journals that are not widely cataloged. Some summaries describe the material as a tuftsin analog and others as a synthetic heptapeptide; the labels overlap rather than conflict. Citing the primary sequence resolves ambiguity more reliably than the research or trade name alone.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, written TKPRPGP in one-letter notation. Its structure consists of the immunomodulatory tetrapeptide tuftsin, Thr-Lys-Pro-Arg, extended at the carboxyl terminus by a Pro-Gly-Pro segment. The molecular formula is commonly given as C33H57N11O9, corresponding to a monoisotopic mass near 751.4 Da and an average molecular mass near 751.9 Da. All seven residues are proteinogenic amino acids, and the molecule carries no modified side chains or non-natural linkages.
The compound was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences during the 1980s and 1990s. The stated design goal was to retain the immunomodulatory and central nervous system activity attributed to tuftsin while improving resistance to enzymatic breakdown. Adding a proline-rich tail to the short parent peptide was a deliberate strategy, because proline residues restrict the conformations available to many peptidases. The same laboratory produced Semax, an ACTH fragment analog, and both compounds were developed in parallel as short, enzymatically stabilized peptides intended for intranasal use.
Measuring peptide exposure inside the brain is technically difficult. Selank is degraded rapidly in plasma, and assays must separate intact peptide from fragments, which favors targeted mass spectrometry over immunoassays alone. Reported half-lives are short, on the order of minutes, so effects observed hours later are attributed to downstream signaling rather than to the parent compound. Blood-brain barrier permeability is debated and rarely quantified directly. Gaps include absent dose-response characterization, inconsistent reporting of purity, and almost no pharmacokinetic data from human participants.
Selank is studied chiefly as an animal-model anxiolytic with proposed secondary effects on memory and immune signaling. Reported mechanisms include modulation of the GABA-A receptor complex, inhibition of enkephalin-degrading enzymes, and shifts in monoamine turnover within limbic structures. Some experiments describe increased expression of brain-derived neurotrophic factor in the hippocampus after repeated dosing. No single molecular target has been confirmed, and the peptide does not bind any receptor with the selectivity typical of a conventional small-molecule drug. Mechanism therefore remains a set of hypotheses rather than an established pathway.
Laboratory work relies on standard behavioral paradigms. Rodents are tested in the elevated plus maze, open field, and passive avoidance tasks, with outcomes compared against diazepam or vehicle controls. Intranasal dosing is used most often because it bypasses first-pass metabolism, though intraperitoneal and intravenous routes also appear in published protocols. Biochemical endpoints include tissue BDNF concentrations, cytokine levels, and monoamine metabolites. Human data are limited to small Russian trials reporting reduced anxiety scores; most were not prospectively registered, and few employed independent outcome assessment.
Peptide stability depends strongly on temperature, moisture, and pH. Lyophilized Selank is generally most stable when stored cold and dry, with freezer temperatures commonly used for long-term storage. In solution, the compound is susceptible to hydrolysis and to microbial growth if it is not handled aseptically. The C-terminal proline-rich extension appears to slow enzymatic cleavage relative to tuftsin, though quantitative degradation rates vary with the matrix and the conditions tested. Published stability data specific to Selank remain sparse.
Quality assessment of Selank samples typically combines purity determination with identity confirmation and counter-ion analysis. Purity is usually reported as a percentage by chromatographic area, with values above 95 percent often quoted for research-grade material. Water content and residual solvents are checked in lyophilized batches because they affect both stability and accurate mass determination. A reported purity figure does not by itself establish that a sample is the intended sequence, so orthogonal methods are needed to rule out sequence isomers or truncation products.
Characterization of Selank in laboratory settings relies on standard peptide analytical techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and degradation products, while mass spectrometry confirms molecular identity through accurate mass measurement. Amino acid analysis and peptide sequencing verify the primary structure when reference material is unavailable. Because Selank is a short chain, fragmentation-based analysis produces a diagnostic ion pattern that supports confident identification.
=== Core-rim zoning === Core-rim zoning is usually associated with the fluid-assisted dissolution-precipitation in metamorphic reactions, forming successive rims each with a new composition. The fluid composition and metamorphic grade (H/T) are important factors in the rim composition.
Similar effects of compound 22 were found for amphetamine- and cocaine-induced stereotypy in normal mice and TAAR1 knockout mice. On the basis of the preceding findings, it was concluded that compound 22 augments psychostimulant-induced hyperlocomotion in a manner that is partially or fully independent of TAAR1 antagonism. The biological targets and mechanisms of compound 22 mediating these effects are unknown.
1 May A preprint indicates Omicron subvariants BA.4 and BA.5 can cause a large share of reinfections, beyond the increase of reinfections caused by the Omicron lineage, even for people who were infected by Omicron BA.1 due to increases in immune evasion, especially for the unvaccinated. On 18 May, a study shows that immunity from an Omicron infection for unvaccinated and previously uninfected is weak "against non-Omicron variants". A preprint suggests that SARS-CoV-2 antibodies in or transmitted through the air are an unrecognized mechanism by which, transferred, passive immune protection occurs. However, if not sustained, protection from passive herd immunity is thought to wane over the course of weeks to months. 4 May NASA reports the sonification (converting astronomical data associated with pressure waves into sound) of the black hole at the center of the Perseus galaxy cluster. A single master gene that programs ear hair cells into either outer or inner ones is discovered, overcoming a major hurdle that had prevented the development of these cells to reverse hearing loss. A study complements life-cycle assessment studies, showing substantial deforestation reduction (56%) and climate change mitigation if only 20% of per-capita beef was replaced by microbial protein by 2050. A study suggests, using an epidemiological model, that by reducing the transferred viral load, face masks against COVID19 may be beneficial for variolation whereby "smaller infectious doses tend to yield milder infections, yet ultimately induce similar levels of immunity".
=== Direct algicidal mechanisms === Direct algicidal mechanisms include methods in which bacterial cells physically interact with algal cells. For example, Streptomyces globisporus strain G9 utilizes hyphae to entrap Microcystis aeruginosa, shading the phytoplankton from sunlight, causing photoinhibition. Another example is compound production triggered by direct cell contact. For instance, Chitinimonas prasina strain LY03 attaches to diatoms that contain chitin in their cell walls directed by their bacterial flagellum, and then produce chitinases that cause diatom lysis. In some instances, locally concentrated compounds have to reach specific levels in order to become algicidal.
=== EC 1.21.99 With unknown physiological acceptors === EC 1.21.99.1 EC 1.21.99.1: β-cyclopiazonate dehydrogenase EC 1.21.99.2: Now classified as EC 1.21.98.1, cyclic dehypoxanthinyl futalosine synthase. EC 1.21.99.3: thyroxine 5-deiodinase EC 1.21.99.4: thyroxine 5′-deiodinase EC 1.21.99.5: tetrachloroethene reductive dehalogenase
Sources: en.wikipedia.org
=== Apical Delta and Accessory Canals === Many teeth have a complex apical delta, consisting of many small accessory foramina branching from the main apical foramen. Each accessory canal is lined with connective tissue continuous with the pulp and periodontal ligament.
== Taxonomic distribution and evolutionary advantages == Action potentials are found throughout multicellular organisms, including plants, invertebrates such as insects, and vertebrates such as reptiles and mammals. Sponges seem to be the main phylum of multicellular eukaryotes that does not transmit action potentials, although some studies have suggested that these organisms have a form of electrical signaling, too. The resting potential, as well as the size and duration of the action potential, have not varied much with evolution, although the conduction velocity does vary dramatically with axonal diameter and myelination.
Rilwanu Lukman- former Minister of Petroleum Resources and Mines, Power, Steel; and former secretary general OPEC. Maikanti Baru - engineer, former GMD Of NNPC Limited. Mohammed Bello-Koko - former managing director of the Nigerian Ports Authority Muhammed Babandede - former Comptroller General (CG) of the Nigeria Immigration Service NIS. Ahmad Salihijo Ahmad - former managing director of Nigerian Rural Electrification Agency. M.T. Usman - former permanent secretary ministry of Works. Abubakar Dantsoho - Managing Director of the Nigerian Ports Authority (NPA). Hamman Bello - former Comptroller- General Of Nigeria Customs Service. Musa Yar'Adua - Minister of Lagos Affairs 1960 -1966, Matawalle of the Katsina Emirate. Muhammadu Ribadu – first minister of defence after independence, founder of the Nigerian Defence Academy. Mansur Muhtar – economist, former Nigerian Federal minister of finance (2008 -2010), former director World Bank, presently vice chairman, Islamic Development Bank. Tajudeen Abbas - Speaker of the House of Representatives of Nigeria. Abubakar Olusola Saraki – (Fulani/Yoruba); former president of the Senate. Gbemisola Ruqayyah Saraki – (Fulani/Yoruba); former Senator Kwara Central, current Minister of State. Transportation of the Federal Republic of Nigeria. Nigeria. Aisha Dikko - former attorney general, commissioner of Justice Kaduna. Bukola Saraki – (Fulani/Yoruba); former president of the Nigerian Senate; former Governor of Kwara State and former Senator Kwara Central, Nigeria. Captain Muhammad Bala Shagari – politician, former Nigerian Army officer.
Scar free healing is the process by which significant injuries can heal without permanent damage to the tissue the injury has affected. In most healing, scars form due to the fibrosis and wound contraction, however in scar free healing, tissue is completely regenerated. During the 1990s, published research on the subject increased; it is a relatively recent term in the literature. Scar free healing occurs in foetal life but the ability progressively diminishes into adulthood. In other animals such as amphibians, however, tissue regeneration occurs, for example as skin regeneration in the adult axolotl.
=== Shelby's Legendary Shawarma === Shelby's Legendary Shawarma is a shawarma fast food chain that has 42 locations, primarily in Ontario owned by Shelby's Franchise Holdings, Inc. headquartered in Oakville, Ontario. It was founded in 2015 when two Arab men from London, Ontario, Yazan El-Shalabi and Yasser Ali (also known by his public persona of "Shawarma Man") opened a food truck replacing a food trailer in nearby Lambeth originally catering to University of Western Ontario students. After opening its permanent brick-and-mortar location in 2018, Shelby's now operates over 40 locations across Ontario located in the Greater Toronto Area, Ottawa, and southwestern Ontario with plans to expand outside of Ontario, particularly in Western Canada, and internationally, in the United States and United Kingdom in the future. This restaurant serves shawarma wraps, rice bowls, poutines, maneesh and churros. It has a social media presence on YouTube, TikTok, Instagram, X (Twitter) and Facebook.
Sources: en.wikipedia.org
Chetumal province, which encompassed the area around Corozal Bay Dzuluinicob province, which encompassed the area between the lower New River and the Sibun River, west to Tipu a southern territory controlled by the Manche Ch'ol Maya, encompassing the area between the Monkey River and the Sarstoon River.
Sprouting occurs at a rate of several millimeters per day, and enables new vessels to grow across gaps in the vasculature. It is markedly different from splitting angiogenesis because it forms entirely new vessels as opposed to splitting existing vessels.
==== Starch granules ==== Starch granules are very common in chloroplasts, typically taking up 15% of the organelle's volume, though in some other plastids like amyloplasts, they can be big enough to distort the shape of the organelle. Starch granules are simply accumulations of starch in the stroma, and are not bounded by a membrane. Starch granules appear and grow throughout the day, as the chloroplast synthesizes sugars, and are consumed at night to fuel respiration and continue sugar export into the phloem, though in mature chloroplasts, it is rare for a starch granule to be completely consumed or for a new granule to accumulate. Starch granules vary in composition and location across different chloroplast lineages. In red algae, starch granules are found in the cytoplasm rather than in the chloroplast. In C4 plants, mesophyll chloroplasts, which do not synthesize sugars, lack starch granules.
==== Conventional recycle processes ==== In early "straight-through" urea plants, reactant recovery (the first step in recycling) was done by letting down the system pressure to atmospheric to let the carbamate decompose back to ammonia and carbon dioxide. Originally, because it was not economic to recompress the ammonia and carbon dioxide for recycle, the ammonia at least would be used for the manufacture of other products such as ammonium nitrate or ammonium sulfate, and the carbon dioxide was usually wasted. Later process schemes made recycling unused ammonia and carbon dioxide practical. This was accomplished by the "total recycle process", developed in the 1940s to 1960s and now called the conventional recycle process. It proceeds by depressurizing the reaction solution in stages (first to 1.8–2.5 MPa (260–360 psi) and then to 0.2–0.5 MPa (29–73 psi)) and passing it at each stage through a steam-heated carbamate decomposer, then recombining the resulting carbon dioxide and ammonia in a falling-film carbamate condenser and pumping the carbamate solution back into the urea reaction vessel.
== Diagnosis == The diagnosis of androgenic alopecia can usually be established based on clinical presentation in men. In women, the diagnosis usually requires a more complex diagnostic evaluation. Further evaluation of the differential requires exclusion of other causes of hair loss, and assessing for the typical progressive hair loss pattern of androgenic alopecia. Trichoscopy can be used for further evaluation. Biopsy may be needed to exclude other causes of hair loss, and histology would demonstrate perifollicular fibrosis. The Hamilton–Norwood scale has been developed to grade androgenic alopecia in males by severity.
Sources: en.wikipedia.org
Reverse-phase HPLC is the usual method and gives a percentage purity value. Mass spectrometry then confirms the molecular mass. Together they provide a basic identity and purity profile for a lot.
Freeze-dried material is kept frozen, often at minus 20 degrees Celsius, and protected from light and moisture. Dissolved peptide is refrigerated for short-term use. Repeated freeze-thaw cycles are avoided.
A certificate of analysis typically lists purity by HPLC, the confirmed mass, appearance, and sometimes water or counter-ion content. It documents results for a specific batch. Details vary by supplier.
Most published work uses intranasal application, either as drops or as a nasal spray. Injection routes appear in a smaller set of animal experiments. Oral use is uncommon in the literature because peptide breakdown and poor absorption limit this route.